 |
Two Paeds In A PodHome of the 'Two Paeds In a Pod' Podcast from the Author: Dr Ian Lewins
Home of the 'Two Paeds In a Pod' Podcast from the Department of Paediatrics at the Royal Derby Hospital. Created by Sarah Simons, Geoff Burnhill and Ian Lewins this medical education podcast is aimed at health care professionals new to paediatrics or those who occasionally care for children as part of a wider healthcare role. This podcast is for medical education purposes only and should not replace advice you have received from a medical practitioner. Language: en Genres: Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
IV Aminophylline in Acute Severe Asthma: Does It Still Have a Role in Paediatric Emergency Care?
Saturday, 25 October, 2025
Clinical QuestionIn children presenting with acute severe asthma, does intravenous aminophylline improve meaningful clinical outcomes compared to standard therapy?⸻BackgroundIV aminophylline has historically been used as a second-line infusion in severe paediatric asthma. However, contemporary escalation strategies increasingly prioritise: • Oxygen • High-dose nebulised salbutamol • Systemic corticosteroids • IV magnesium sulphateThis raises the question: does aminophylline still offer incremental benefit?⸻The Evidence ReviewedA systematic review published in Archives of Disease in Childhood analysed: • 9 randomised controlled trials • 466 children • Standard therapy ± IV aminophyllineOutcomes assessed: • Asthma severity scores • Length of stay • Admission rates • PICU admission • Intubation rates • Adverse effects⸻Key FindingsNo significant benefit in: • Speed of clinical improvement • Admission rates • PICU transfer • Intubation rates • Length of hospital staySignificant increase in adverse effects: • Nausea and vomiting (3–5x higher) • Headache • Tremor • Irritability • ArrhythmiasOverall: No improvement in meaningful outcomes, with increased morbidity.⸻Important CaveatA 1998 study (Young & South) suggested possible benefit in the most critically unwell, treatment-refractory children, including: • Reduced duration of intubation • Potential improvement in lung functionThis suggests a potential narrow rescue-therapy window.⸻Implications for Paediatric Emergency Practice (2025)Current best evidence supports: 1. Oxygen 2. Nebulised salbutamol 3. Systemic corticosteroids 4. IV magnesium 5. Structured escalation planningIV aminophylline should be considered: • A rescue therapy of last resort • Not routine second-line treatment⸻Take-Home MessageIV aminophylline has historical presence but limited modern evidence of benefit. For most children with acute severe asthma, it increases adverse effects without improving outcomes.Its role in 2025: rare, selective, and critically contextual.
